SIMABS
Timeline
21 events since 2019Deadline for the 2026 accounts: 31-07-2027
Capital increase of €1,500,000 to €6,221,600Capital from €4,721,600 to €6,221,600, 20,280,378 new shares · General meeting of 06-03-20263 points ▸
- General meeting, 06-03-2026
- Capital increase, €1,500,000
- Capital, €6,221,600
- The deed holds 1 more point.
5 directors appointed, 7 resignationsCapital from €1,906,600 to €3,241,600, 18,049,537 new shares · Capital from €4,271,600 to €5,771,600, 20,280,378 new shares · Contribution of €1,480,000 · General meeting of 16-12-202523 points ▸
- Capital, €4,721,600, 171,878,728 shares
- Director resignation, Pilot Biologix
- Director resignation, EYE-TEC
- Director resignation, Oak Projects
- Director resignation, Metatron Holding
- Director resignation, Chemscienses Middle East Fzc
- Director resignation, Vandermarliere Nicolas
- Director resignation, Quality for You
- Permanent representative, Koen Dierckx
- Permanent representative, Bram Keymolen
- Permanent representative, Joachim Vandeput
- Permanent representative, Jo Nelissen
- Permanent representative, Amit Tibrewala
- Permanent representative, Bart Van Acker, mentioned twice in the deed
- Director appointment, QBD GROWTH
- Director appointment, Pilot Biologix
- Director appointment, Metatron Holding
- Director appointment, Chemscienses Middle East Fzc
- Director appointment, VANDECRUYS Amber
- General meeting, 16-12-2025
- Capital increase, €1,335,000
- Capital contribution, €1,480,000
- Capital increase, €1,500,000
- The deed holds 8 more points.
1 director appointedChemsciences Middle East Fzc · Permanent representatives: Amit Tibrewala and Koen Dierckx · General meeting of 30-06-20254 points ▸
- General meeting, 30-06-2025
- Director appointment, Chemsciences Middle East Fzc
- Permanent representative, Amit Tibrewala
- Permanent representative, Koen Dierckx
Capital increaseGeneral meeting of 14-08-20241 point ▸
- General meeting, 14-08-2024
- The deed holds 8 more points.
Capital increase of €831,600 to €1,906,600Capital from €1,075,000 to €1,906,600, 36,728,999 new shares · Reappointments: Pilot Biologix, EYE-TEC, Oak Projects and Quality for You · Permanent representatives: DIERCKX August Koen, KEYMOLEN Bram, VANDEPUT Joachim, VAN ACKER Bart and NELISSEN Jo · General meeting of 25-09-202319 points ▸
- General meeting, 25-09-2023
- Capital increase, €831,600
- Capital, €1,906,600, 125,062,332 shares
- Director reappointment, Pilot Biologix (class A director)
- Director reappointment, EYE-TEC (class A director)
- Director reappointment, Oak Projects (class A director)
- Director reappointment, Quality for You (class A director)
- Director discharge, Pilot Biologix
- Director discharge, EYE-TEC
- Director discharge, Oak Projects
- Director discharge, Quality for You
- Permanent representative, DIERCKX August Koen
- Permanent representative, KEYMOLEN Bram
- Permanent representative, VANDEPUT Joachim
- Permanent representative, VAN ACKER Bart
- Director appointment, VANDERMARLIERE Nicolas (class B director)
- Director appointment, METATRON HOLDING (class B director)
- Permanent representative, NELISSEN Jo
- Power of attorney, Ann SCHAEKEN
- The deed holds 8 more points.
Permanent representatives: Bram Keymolen and Koen DierckxBoard meeting of 15-03-20223 points ▸
- Board meeting, 15-03-2022
- Permanent representative, Bram Keymolen
- Permanent representative, Koen Dierckx
Capital increase of €575,000 to €1,075,000Capital from €500,000 to €1,075,000, 38,333,333 new shares · Resignation: JTR CONSULTING (director) · Permanent representative: Johan Trouwers · General meeting of 21-12-20218 points ▸
- General meeting, 21-12-2021
- Capital increase, €575,000
- Capital, €1,075,000
- Amendment of the articles, article 5
- Director resignation, JTR CONSULTING
- Permanent representative, Johan Trouwers
- Director discharge, JTR CONSULTING
- Power of attorney, Ann SCHAEKEN
- The deed holds 1 more point.
Capital increase of €400,000 to €500,000Capital from €100,000 to €500,000, 40,000,000 new shares · General meeting of 22-10-20203 points ▸
- General meeting, 22-10-2020
- Capital increase, €400,000
- Amendment of the articles, article 5
IncorporationFounding capital of €100,000, 10,000,000 shares · Founders: PILOT BIOLOGIX, Oak Projects, JTR CONSULTING and 2 others · Appointments: PILOT BIOLOGIX, Oak Projects, JTR CONSULTING, EYE-TEC and QUALITY FOR YOU · published on 22-08-201918 points ▸
- Founder, PILOT BIOLOGIX
- Founder, Oak Projects
- Founder, JTR CONSULTING
- Founder, EYE-TEC
- Founder, QUALITY FOR YOU
- Founding capital, €100,000, 10,000,000 shares
- Registered office clause, 3590 Diepenbeek, Agoralaan Abis
- Board rule, 5
- Director appointment, PILOT BIOLOGIX
- Permanent representative, August Koen Dierckx
- Director appointment, Oak Projects
- Permanent representative, Joachim Vandeput
- Director appointment, JTR CONSULTING
- Permanent representative, Johan Trouwers
- Director appointment, EYE-TEC
- Permanent representative, Bram Keymolen
- Director appointment, QUALITY FOR YOU
- Permanent representative, Bart Van Acker
- The deed holds 2 more points.
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
SIMABS was incorporated on 20 August 2019 as a public limited company by PILOT BIOLOGIX, Oak Projects and three other companies, with a starting capital of €100,000.12 Between 2020 and 2026 the capital was increased 5 times, most recently to €6.2m.345 The board currently has 4 members.6 Total assets rose from €1.4m in 2020 to €2.7m in 2025 and headcount from 1.3 to 11.4 full-time equivalents.7